抑制肌醇激酶B控制急性和慢性移植物抗宿主病
本研究通过遗传学和药理学方法抑制Itpkb信号控制GVHD。Itpkb-/- T细胞减轻急性GVHD且保留GVL;选择性抑制剂GNF362改善急性GVHD而不损害GVL,并较FK506更选择性删除同种反应性T细胞;在慢性GVHD模型中,Itpkb-/- T细胞和GNF362均减少活动性慢性GVHD。
要点
- 抑制Itpkb可减轻急性GVHD并保留移植物抗白血病效应
- GNF362较FK506更选择性删除供者同种反应性T细胞
- Itpkb信号是驱动急性和慢性GVHD的关键通路
核心结论
- 完整的Itpkb信号是驱动急性GVHD发病和维持活动性慢性GVHD所必需的,提示其作为预防急性或治疗慢性GVHD的新临床靶点。
研究设计与样本
- 研究采用遗传学(Itpkb-/- T细胞)和药理学(选择性抑制剂GNF362)方法,在多种小鼠模型中评估对急性和慢性GVHD及GVL的影响。
主要发现
- Itpkb-/- T细胞在2个模型中减轻急性GVHD且不消除A20-luciferase B细胞淋巴瘤的GVL。
- GNF362改善急性GVHD且不损害对2种急性髓系白血病细胞系(MLL-AF9-eGFP和C1498-luciferase)的GVL。
- 与FK506相比,GNF362更选择性删除供者同种反应性T细胞而非名义抗原反应性T细胞。
- 与FK506相比,GNF362对MLL-AF9-eGFP细胞具有更有利的急性GVHD和GVL特性。
- 在慢性GVHD模型中,Itpkb-/-供者T细胞减少多器官系统闭塞性细支气管炎(BO)模型的活动性慢性GVHD;GNF362减少BO和硬皮病模型的活动性慢性GVHD。
临床怎么用
- 抑制Itpkb信号可能作为预防急性GVHD或治疗慢性GVHD的新策略,且可能保留GVL效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
T-cell activation releases inositol 1,4,5-trisphosphate (IP3), inducing cytoplasmic calcium (Ca2+) influx. In turn, inositol 1,4,5-trisphosphate 3-kinase B (Itpkb) phosphorylates IP3 to negatively regulate and thereby tightly control Ca2+ fluxes that are essential for mature T-cell activation and differentiation and protection from cell death. Itpkb pathway inhibition increases intracellular Ca2+, induces apoptosis of activated T cells, and can control T-cell-mediated autoimmunity. In this study, we employed genetic and pharmacological approaches to inhibit Itpkb signaling as a means of controlling graft-versus-host disease (GVHD). Murine-induced, Itpkb-deleted (Itpkb-/-) T cells attenuated acute GVHD in 2 models without eliminating A20-luciferase B-cell lymphoma graft-versus-leukemia (GVL). A highly potent, selective inhibitor, GNF362, ameliorated acute GVHD without impairing GVL against 2 acute myeloid leukemia lines (MLL-AF9-eGFP and C1498-luciferase). Compared with FK506, GNF362 more selectively deleted donor alloreactive vs nominal antigen-responsive T cells. Consistent with these data and as compared with FK506, GNF362 had favorable acute GVHD and GVL properties against MLL-AF9-eGFP cells. In chronic GVHD preclinical models that have a pathophysiology distinct from acute GVHD, Itpkb-/- donor T cells reduced active chronic GVHD in a multiorgan system model of bronchiolitis obliterans (BO), driven by germinal center reactions and resulting in target organ fibrosis. GNF362 treatment reduced active chronic GVHD in both BO and scleroderma models. Thus, intact Itpkb signaling is essential to drive acute GVHD pathogenesis and sustain active chronic GVHD, pointing toward a novel clinical application to prevent acute or treat chronic GVHD.
引用
- Thangavelu G, Du J, Paz KG, et al. Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease. Blood. 2020. PMID: 31697815. doi:10.1182/blood.2019000032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。